Mutations in NF1 in SCs are the initial tumor-forming event that leads to either complete loss or substantial reduction of neurofibromin function, resulting in hyperactivation of RAS and multiple downstream signaling pathways [712,725]. Here, NF1 is linked to neoplasm.